NCT01349036 A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma Status TERMINATED Phase PHASE2
NCT01345019 Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01327534 Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI Status COMPLETED Phase PHASE3
NCT01290471 Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors Status COMPLETED Phase PHASE1
NCT01288430 A Study of DS-2248 in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT01287858 Study to Assess Safety, Tolerability, and Pharmacokinetics of Oral Doses for AC430 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01260584 The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease Status COMPLETED Phase PHASE4
NCT01245543 Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors Status WITHDRAWN Phase PHASE1
NCT01244191 Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Status TERMINATED Phase PHASE3
NCT01220999 A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT01217229 Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT01211483 Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01149720 Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01124630 Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments Status COMPLETED Phase PHASE1
NCT01122108 Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) Scale Status COMPLETED Phase PHASE4
NCT01101334 Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2